Abstract | OBJECTIVE: METHODS: Thirty-five cases of endometrial carcinoma were examined by immunohistochemistry. Clinicopathologic features including FIGO stage, histological grade, myometrial invasion and nodal metastasis were reviewed. RESULTS: The expression rate of ERalpha in patients with FIGO stage I endometrial carcinoma was more than that in stage II-IV(P = 0.005). The expression rate of ERRalpha in endometrial carcinoma patients at FIGO stage I was lower than that at stages II-IV(P = 0.007). The percentage of patients at FIGO stageI or with G1-2 or myometrial invasion < 1/2 in ERalpha (+) and ERRalpha (-) groups was higher than that in ERalpha (-) and ERRalpha (+) groups(P = 0.000, P = 0.031 and P = 0.022). CONCLUSION:
|
Authors | Min Gao, Li-hui Wei, Peng-ming Sun, Dan Zhao, Xiao-ping Li |
Journal | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
(Beijing Da Xue Xue Bao Yi Xue Ban)
Vol. 38
Issue 5
Pg. 463-5
(Oct 18 2006)
ISSN: 1671-167X [Print] China |
PMID | 17068614
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Estrogen Receptor alpha
- Receptors, Estrogen
|
Topics |
- Adenocarcinoma
(metabolism, pathology)
- Adult
- Aged
- Biomarkers, Tumor
(biosynthesis)
- Endometrial Neoplasms
(metabolism, pathology)
- Estrogen Receptor alpha
(biosynthesis)
- Female
- Humans
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Prognosis
- Receptors, Estrogen
(biosynthesis)
- ERRalpha Estrogen-Related Receptor
|